Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 5,599,746 shares were traded during trading, an increase of 24% from the previous session's volume of 4,500,903 shares.The stock last traded at $15.54 and had previously closed at $14.15.
Wall Street Analyst Weigh In
OSCR has been the subject of several research analyst reports. Wall Street Zen raised shares of Oscar Health from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $18.50.
Check Out Our Latest Stock Analysis on OSCR
Oscar Health Trading Down 0.5%
The company has a market cap of $3.97 billion, a price-to-earnings ratio of -772.81 and a beta of 1.73. The business's fifty day moving average price is $13.83 and its 200 day moving average price is $14.58. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The business's revenue was up 42.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.62 earnings per share. Research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Insider Transactions at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 24.39% of the stock is currently owned by insiders.
Institutional Trading of Oscar Health
Hedge funds and other institutional investors have recently modified their holdings of the business. Jones Financial Companies Lllp increased its holdings in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio purchased a new stake in Oscar Health during the 1st quarter valued at $30,000. Larson Financial Group LLC lifted its position in shares of Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after purchasing an additional 2,512 shares during the period. CWM LLC lifted its position in shares of Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after purchasing an additional 1,078 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its stake in shares of Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock worth $45,000 after acquiring an additional 2,854 shares in the last quarter. Institutional investors own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
